Efficacy of Nerve Block Versus Botox in Chronic Migraine Management
Status:
RECRUITING
Trial end date:
2025-07-10
Target enrollment:
Participant gender:
Summary
The goal of this clinical trial is to determine whether nerve block injections (specifically, supratrochlear and greater occipital nerve injections) are as effective as Botulinum toxin A (Botox) injections in treating chronic migraine in adults.
The main questions it aims to answer are:
* Do nerve block injections reduce the number of monthly migraine days compared to baseline?
* Are there any differences in the frequency of migraine-related symptoms between the nerve block and Botox treatment groups?
* Which treatment leads to higher patient satisfaction and improved quality of life?
Participants in this study will:
* Receive either nerve block injections or Botox injections every 12 weeks.
* Visit the clinic once every month for follow-ups and assessments.
* Maintain a headache diary to record the frequency and severity of their migraines and any adverse effects experienced.
* Researchers will compare the outcomes of the two groups to determine if one treatment is superior in terms of efficacy and patient satisfaction.